These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8222855)

  • 41. Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block.
    Kotake Y; Ochiai R; Suzuki T; Ogawa S; Takagi S; Ozaki M; Nakatsuka I; Takeda J
    Anesth Analg; 2013 Aug; 117(2):345-51. PubMed ID: 23757472
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Anesthesia for a patient with spinocerebellar degeneration--with special reference to neuromuscular blockade monitoring].
    Tanaka S; Iwasaki H; Namiki A
    Masui; 1994 Feb; 43(2):250-2. PubMed ID: 8164332
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sedation, pain relief, and neuromuscular blockade in the postoperative cardiac surgical patient.
    Coyle JP
    Semin Thorac Cardiovasc Surg; 1991 Jan; 3(1):81-7. PubMed ID: 1673061
    [No Abstract]   [Full Text] [Related]  

  • 44. [Rocuronium used in rapid sequence intubation and reversal with sugammadex in a patient with myasthenia gravis].
    Illodo Miramontes G; Doniz Campos M; Filgueira Garrido P; Vázquez Martínez A
    Rev Esp Anestesiol Reanim; 2011 Dec; 58(10):626-7. PubMed ID: 22263415
    [No Abstract]   [Full Text] [Related]  

  • 45. Recurarization after sugammadex following a prolonged rocuronium infusion for induced hypothermia.
    Murata T; Kubodera T; Ohbayashi M; Murase K; Adachi YU; Matsuda N
    Can J Anaesth; 2013 May; 60(5):508-9. PubMed ID: 23460187
    [No Abstract]   [Full Text] [Related]  

  • 46. Sugammadex: a novel approach to reversal of neuromuscular blockade.
    Aniskevich S; Leone BJ; Brull SJ
    Expert Rev Neurother; 2011 Feb; 11(2):185-98. PubMed ID: 21306205
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Use of sugammadex after neostigmine incomplete reversal of rocuronium-induced neuromuscular blockade.
    de Menezes CC; Peceguini LA; Silva ED; Simões CM
    Rev Bras Anestesiol; 2012 Jul; 62(4):543-7. PubMed ID: 22793970
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reasoning of an anomaly: residual block after sugammadex.
    Naguib M; Brull SJ; Arkes HR
    Anesth Analg; 2013 Aug; 117(2):297-300. PubMed ID: 23881373
    [No Abstract]   [Full Text] [Related]  

  • 49. [Neuromuscular blockade monitoring].
    Gutiérrez García R; Abad Gurumeta A; Aramburu Uriarte O; Cortina de Castro I; Ocón JI
    Rev Esp Anestesiol Reanim; 2011 Jun; 58 Suppl 2():8-13. PubMed ID: 21916084
    [No Abstract]   [Full Text] [Related]  

  • 50. Open forum--neuromuscular blockade to optimize ventilation is becoming common. How does your unit assess/monitor blockade level?
    Snook MM; Rohan J; Williams C; Schell H
    Crit Care Nurse; 1994 Oct; 14(5):113-4. PubMed ID: 7859461
    [No Abstract]   [Full Text] [Related]  

  • 51. [Application of atracurium to critical care patients in ICU].
    Zheng H; Lin Y; Chen S
    Zhonghua Wai Ke Za Zhi; 1997 Feb; 35(2):125-6. PubMed ID: 10374495
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A review of neuromuscular blockade in the critically ill patient.
    Burry L; HoSang M; Hynes-Gay P
    Dynamics; 2001; 12(3):28-33; quiz 34-5. PubMed ID: 11982205
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The impact of implementation of neuromuscular blockade monitoring standards in a surgical intensive care unit.
    Frankel H; Jeng J; Tilly E; St Andre A; Champion H
    Am Surg; 1996 Jun; 62(6):503-6. PubMed ID: 8651538
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Erroneous attitudes in the use of neuromuscular blocking agents].
    Ortiz-Gómez JR
    Rev Esp Anestesiol Reanim; 2002 Feb; 49(2):65-8. PubMed ID: 12025249
    [No Abstract]   [Full Text] [Related]  

  • 55. [Use of nondepolarizing myorelaxants in neonates].
    Shabanova SK; Mikhel'son VA; Zhirkova IuV; Agavelian EG; Shaginian AK; Sepbaeva AD
    Anesteziol Reanimatol; 2008; (1):26-9. PubMed ID: 18368836
    [No Abstract]   [Full Text] [Related]  

  • 56. Reversal of moderate and intense neuromuscular block induced by rocuronium with low doses of sugammadex for intraoperative facial nerve monitoring.
    Fabregat López J; Porta Vila G; Martin-Flores M
    Rev Esp Anestesiol Reanim; 2013 Oct; 60(8):465-8. PubMed ID: 23664256
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Clinical differentiation of the modes of action of muscle relaxants].
    Mori K; Yamamura Y; Fujita M
    Masui; 1971 Nov; 20(12):1087-94. PubMed ID: 4260219
    [No Abstract]   [Full Text] [Related]  

  • 58. Objective monitoring of neuromuscular block should become the standard of care.
    El-Orbany M
    Acta Anaesthesiol Scand; 2009 Jul; 53(6):837. PubMed ID: 19563579
    [No Abstract]   [Full Text] [Related]  

  • 59. Monitoring neuromuscular blockade in the adult ICU.
    Ford EV
    Am J Crit Care; 1995 Mar; 4(2):122-30; quiz 131-2. PubMed ID: 7749444
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Proceedings: Quantifying myoneural block induced relaxation.
    Ragsdale DW; Anderson AD; Long FM
    Biomed Sci Instrum; 1974 Apr; 10():1-5. PubMed ID: 4274721
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.